As they reported, the synthesized BTZ/PC-apoVs could induce apoptosis in MM cells in vitro, whilst significantly ameliorating the inhibition of MM phenotypes and attenuating BTZ toxicity in vivo [122]. The gene discussed is CASC3; the disease is Miyoshi myopathy.